Compass Therapeutics, Inc. (CMPX) vs Oramed Pharmaceuticals Inc. (ORMP)

A side-by-side comparison of Compass Therapeutics, Inc. and Oramed Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CMPX vs ORMP

growth of $100 · dividends reinvested · last 6y
CMPX -88.7% (-30.5%/yr)ORMP -52.4% (-11.6%/yr)ORMP compounded faster over this window
0100200Start $10020222023202420252026$11$48
CMPX ORMP

CMPX vs ORMP: by the numbers

  • •ORMP is the larger company ($182M vs $175M market cap).
  • •ORMP is profitable (3202.50% net margin) while CMPX runs a net loss (0.00%).
  • •ORMP pays a dividend (5.59% yield), while CMPX has no payments in the available dividend history.

Metrics side by side

Valuation

MetricCMPXORMP
P/E ratioN/A1.08
P/B ratio1.060.57

Profitability

MetricCMPXORMP
Gross margin0.00%0.65%
Operating margin0.00%-754.40%
Net margin0.00%3202.50%
ROE-44.23%55.08%
ROIC-46.59%-3.21%

Dividends

MetricCMPXORMP
Dividend yieldN/A5.59%
Payout ratioN/A6.08%

Growth (annualized)

MetricCMPXORMP
Total return CAGR (5Y)-22.79%-25.80%

Frequently asked

Does CMPX or ORMP pay a bigger dividend?
ORMP pays a dividend (5.59% yield), while CMPX has no payments in the available dividend history.
Is CMPX or ORMP more profitable?
ORMP runs the higher net margin — CMPX at 0.00% versus ORMP at 3202.50%.
How have CMPX and ORMP total returns compared?
Over the past 5 years, CMPX delivered -22.79% and ORMP delivered -25.80% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.